[1]郭睿,黄小钟,金雪媛,等.地尔硫卓通过下调钙激活氯离子通道抑制肝癌细胞增殖和运动[J].南方医科大学学报,2018,(07):818.
点击复制

地尔硫卓通过下调钙激活氯离子通道抑制肝癌细胞增殖和运动()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2018年07期
页码:
818
栏目:
出版日期:
2018-06-30

文章信息/Info

Title:
Diltiazem inhibits proliferation and motility of hepatocellular cells in vitro by downregulating calcium-activated chloride channel TMEM16A
作者:
郭睿黄小钟金雪媛杨军
关键词:
肝细胞癌侵袭转移钙激活氯离子通道蛋白TMEM16A地尔硫卓
Keywords:
calcium channel inhibitors diltiazem hepatocellular carcinoma invasion metastasis calcium- activated chloride channels TMEM16A calcium inhibitors
摘要:
目的观察钙离子通道抑制剂地尔硫卓对肝癌MHCC97H、7402细胞增殖和运动侵袭能力的作用,探讨其相应机制。方 法采用不同浓度地尔硫卓(0、25、50、100、200、400 μmol/L)干预肝癌MHCC97H、7402细胞不同时间(12、24、48 h)后,用MTT 法测定地尔硫卓对肝癌细胞增殖的影响,体外细胞划痕实验检测处理后肝癌细胞运动侵袭能力;通过RT-PCR和免疫细胞化学 检测地尔硫卓对肝癌细胞中TMEM16A mRNA和蛋白表达水平的影响。结果地尔硫卓能够有效抑制肝癌MHCC97H、7402 细胞的增殖和运动侵袭能力,且具有一定的时间和浓度依赖性特点(P<0.05)。其中,100 μmol/L浓度的地尔硫卓作用24 h对 MHCC97H肝癌细胞抑制较明显,TMEM16AmRNA和蛋白表达减少(P<0.05),而50 μmol/L浓度的地尔硫卓作用48 h对7402 肝癌细胞抑制较明显,TMEM16AmRNA和蛋白表达减少(P<0.05)。结论地尔硫卓能一过性抑制MHCC97H、7402肝癌细胞 侵袭,这种作用可能与其通过调节钙离子通道TMEM16A的mRNA和蛋白表达而发挥肿瘤抑制作用有关。
Abstract:
Objective To assess the inhibitory effect of diltiazem, a calcium channel inhibitor, on the proliferation and mobility of human hepatocellular carcinoma cells in vitro and explore the possible mechanism. Methods Two human hepatocellular carcinoma cell lines, MHCC97H and 7402, were treated with different concentrations (0-400 μmol/L) of diltiazem for 12, 24, or 48 h, and the changes in the cell proliferation and mobility were observed with MTT assay and wound healing assay, respectively. The changes in the expressions of calcium-activated chloride channel TMEM16A at mRNA and protein levels in the treated cells were detected using RT-PCR and immunocytochemistry. Results Treatment with diltiazem obviously inhibited the proliferation and suppressed the mobility of MHCC97H and 7402 cells in a time- and concentration-dependent manner (P<0.05). Treatment with 100 μmol/L diltiazem for 24 h significantly inhibited the proliferation of MHCC97H cells and down-regulated the mRNA and protein levels of TMEM16A. In 7402 cells, diltiazem treatment at 50 μmol/L for 48 h resulted in the most significant inhibitory effect on the cell proliferation and TMEM16A expressions. Conclusion Diltiazem can transiently inhibit the invasion of hepatocellular carcinoma cells in vitro possibly by down-regulating the expression of TMEM16A at both the mRNAand protein levels.

相似文献/References:

[1]郭丹,陈娜娜,侯连兵,等.前列腺素E2活化EP2受体促进肝癌细胞增殖[J].南方医科大学学报,2011,(09):1564.
[2]李湘竑,钟克波,刘延,等.索拉菲尼治疗肝癌肝移植术后肿瘤复发患者的疗效及安全性分析[J].南方医科大学学报,2011,(09):1608.
[3]陈可和,梁博,邹镇洪,等.Rheb和Rheb’D60K突变基因重组慢病毒载体的构建、鉴定及其对肝癌细胞凋亡的影响[J].南方医科大学学报,2012,(03):341.
[4]赵爱国,吴曙光.沉默CDK7基因对HepG2细胞株的抗增殖作用[J].南方医科大学学报,2005,(01):58.
 ZHAO Ai-guo,WU Shu-guang.Effect of CDK7 gene silencing against hepatoblastoma HepG2 cell proliferation[J].Journal of Southern Medical University,2005,(07):58.
[5]余元龙,季明芳,何洁冰,等.紫杉醇、5-氟脲嘧啶抑制肝癌细胞BEL-7402生长和诱导凋亡的比较[J].南方医科大学学报,2005,(07):864.
 YU Yuan-long,JI Ming-fang,HE Jie-bing,et al.Effects of paclitaxel and 5-fluorouracil on growth inhibition and apoptosis of hepatoma cells:a comparative study[J].Journal of Southern Medical University,2005,(07):864.
[6]金吴东,陈龙华,穆峰.外源性mTκα基因抑制肝癌细胞HepG2的生长[J].南方医科大学学报,2004,(10):1133.
 JIN Wu-dong,CHEN Long-hua,MU Feng.Exogenous mTκα gene inhibits the growth of HepG2 heptocellular carcinoma cells[J].Journal of Southern Medical University,2004,(07):1133.
[7]陈志丰,梁宏,张祥松,等.肝癌治疗后甲胎蛋白增高患者的18F-FDG PET/CT与增强CT对照研究[J].南方医科大学学报,2012,(11):1615.
[8]李超,涂康生,郑鑫,等.MicroRNA-218在肝细胞癌中的表达及功能[J].南方医科大学学报,2013,(08):1127.
[9]黄俊海,周杰.符合Milan标准肝细胞癌患者行肝移植和肝切除术预后分析[J].南方医科大学学报,2014,(03):406.
[10]陈朝武,周彬,徐莹,等.HBV复制及不同基因表达不影响CDC37水平[J].南方医科大学学报,2014,(06):823.
[11]贺松其,文彬,陈冠新,等.以GSK-3β为靶标的miRNAs调控肝细胞癌侵袭转移的研究进展[J].南方医科大学学报,2017,(01):138.

更新日期/Last Update: 1900-01-01